European Liver Patients' Association | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A-TANGO Phase 2 Study	Acute-On-Chronic Liver Failure, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute liver failure, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, hepatitis, liver disorder, liver failure, substance-related disorder	Recruiting	Phase 2	2026-09-21		NCT06890039
Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).	metabolic dysfunction-associated steatotic liver disease	Not yet recruiting	Not stated	2026-02-24		NCT07430501
10119473 -VIROMARKERS HDV Biomarkers Study	HDV Infection	Not yet recruiting	Not stated	2026-01-22		NCT07313358
Global Research Initiative for Patients Screening on MASH	Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder	Recruiting	Not stated	2024-08-01		NCT05651724